Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody
Jon Kenniston(Massachusetts General Hospital), Daniel J. Sexton(Massachusetts General Hospital), Gregory P. Conley, Robert C. Ladner(MRC Laboratory of Molecular Biology), Petr Kuzmič, Malini Viswanathan, Niksa Kastrapeli, Mike DiLeo, Ryan Faucette(Massachusetts General Hospital), Shauna Mason, Diana Martik, Stephen R. Comeau, Jan Abendroth(Virginia Mason Bainbridge Island Medical Center), Janja Cosic, Kris Kopacz, Allison P Lindberg, Jie Chen(Dana-Farber Cancer Institute), Burt Adelman(Massachusetts General Hospital), Thomas E. Edwards(North Seattle College), Christopher TenHoor(Massachusetts General Hospital), Andrew E. Nixon
Cited by 122
Related Papers
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
|New England Journal of Medicine|1995|496
The structure of horse methaemoglobin at 2.0 Å resolution
|Journal of Molecular Biology|1977|289
Crystal Structures of the Thi-Box Riboswitch Bound to Thiamine Pyrophosphate Analogs Reveal Adaptive RNA-Small Molecule Recognition
|Structure|2006|257
Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO)
|Circulation|1997|232
Synthesis of basement membrane collagen by cultured human endothelial cells.
|The Journal of Experimental Medicine|1976|208